Literature DB >> 32699405

Targeting Lp(a) to reduce ASCVD risk.

Karina Huynh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32699405     DOI： 10.1038/s41569-020-0425-5

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.

Authors:  Rishi Puri; Steven E Nissen; Benoit J Arsenault; Julie St John; Jeffrey S Riesmeyer; Giacomo Ruotolo; Ellen McErlean; Venu Menon; Leslie Cho; Kathy Wolski; A Michael Lincoff; Stephen J Nicholls
Journal:  JAMA Cardiol       Date:  2020-10-01       Impact factor: 14.676
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.